Map | A Partnership for Children's Health Search:  Advanced Search
Home General Information Country Support Board Task Forces Resources Media Center
About the Board Last Board Meeting Members Board Reports EC reports Private Access
Printer-friendly format

Quick Reference:

What is GAVI?

GAVI Fact Sheets

Governance

Board Documents

Guidelines

Press Releases

Immunization Information

Immunization Forum
Latest Issue

GAVI Update

Glossary

Employment

<<BACK TO NINTH GAVI BOARD MEETING

NINTH GAVI BOARD MEETING
Dakar, 18-19 November 2002

10 Vaccine Provision Project

Paper (Word - 155K)

Discussion

  • There are divergent views on the Board concerning the role of industry in the Vaccine Provision Project. Some consider the industry perspective essential for accurate forecasts and to ensure open lines of communication while others consider the potential conflict of interest to be a significant threat. This issue will need to be further explored.


  • As countries become more accustomed to the use of pentavalent DTP-hepB-Hib, vaccine wastage will most likely decrease. However, for forecasting purposes a more generous wastage rate should be considered so that countries do not face stock-outs.


DECISIONS

The Board:

  • 1.1 Endorsed the report of the Oversight Committee.


  • 1.2 Endorsed the forecast methodology chosen while stressing the need for strong involvement of countries in the forecasting process.


  • 1.3 Endorsed the use - for forecasting calculations only - of 10% wastage for the 2-dose pentavalent vaccine.


  • 1.4 Requested guidance in the next update (30 January 2003) on how to approach manufacturers.


  • 1.5 Agreed that Jacques-François Martin should be an additional member of the Oversight Committee in order to contribute his perspective as a former vaccine industry executive.


<<BACK TO NINTH GAVI BOARD MEETING

[ star_int ]   Contact us | Guestbook | Copyrights | Illustrated site